GlobeNewsWire
30 Jun 2026, 13:19 UTC · 17w ago
Impact · against what's priced in
ADMA Biologics faces significant valuation risk due to allegations of channel stuffing that would flip its 2025 growth from 20% to -3%. MCB and ALHC are also under investigation by Lowey Dannenberg, increasing their respective legal and regulatory risk profiles.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
Culper Research alleges ADMA Biologics engaged in channel stuffing to report 20% growth in 2025 when real growth was allegedly -3%.
So whatAllegations of fraudulent revenue inflation and significant overstatement of growth typically lead to severe valuation corrections.
More negative than 99% of claims this week
Lowey Dannenberg P.C. is investigating ADMA Biologics for potential violations of federal securities laws.
Continue reading
5 related stories
Culper Research alleges ADMA reported 20% growth in 2025 through channel stuffing when real growth was -3%, fundamentally undermining the company's reported revenue trajectory.
Read from the article alone
No priced-in read yet
The initiation of an investigation by Lowey Dannenberg for potential federal securities laws violations introduces new legal uncertainty and regulatory risk.
Read from the article alone
No priced-in read yet
The initiation of an investigation by Lowey Dannenberg for potential federal securities laws violations introduces new legal uncertainty and regulatory risk.
Read from the article alone
Scored by the NIS engine · methodology.
Search tags
More negative than 95% of claims this week
Culper Research claims ADMA Biologics used rebates and extended payment terms to induce distributors to stock excess ASCENIV.
More negative than 87% of claims this week
Which stocks this story touches
More negative than 99% of ticker scores this week
The company is under investigation for potential securities law violations and alleged revenue inflation via channel stuffing.
More negative than 92% of ticker scores this week
The company is being investigated by a law firm for potential securities law violations.
More negative than 92% of ticker scores this week
The company is being investigated by a law firm for potential securities law violations.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
1h ago
+32.1%
Price is moving against the score
$11.06 vs $8.37 close before publication (Jun 29) · not market-adjusted
ADMA chart →−69.9%
Price agrees with the score
$7.00 vs $23.26 close before publication (Jun 29) · not market-adjusted
ALHC chart →−1.7%
Price agrees with the score
$97.67 vs $99.34 close before publication (Jun 29) · not market-adjusted
MCB chart →
